Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · ORTHOPEDIATRICS CORP (KIDS)

OrthoPediatrics Q3 revenue rises 19% to $72.7 million; raises 2026 revenue guidance

Positive Impact 4 of 5 guidance Written later

OrthoPediatrics reported third-quarter 2026 revenue of $72.7 million, up 19% from a year earlier, and a net loss of $5.9 million, narrower than the $11.8 million loss in the prior-year quarter. The company raised its full-year 2026 revenue guidance to $270.0 million to $273.0 million from $265.0 million to $269.0 million.

Key points

  • Third-quarter revenue was $72.7 million, up 19% from $61.2 million in the third quarter of 2025.
  • Net loss narrowed to $5.9 million, or $0.25 per share, from $11.8 million, or $0.50 per share, a year earlier.
  • 2026 revenue guidance raised to $270.0 million to $273.0 million from $265.0 million to $269.0 million.
  • Free cash flow was $1.6 million in the quarter, compared with usage of $3.4 million a year earlier.

The filing

CompanyORTHOPEDIATRICS CORP (KIDS)
Form8-K, current report
Filed with the SECOct 27, 2026, 4:07 PM ET
Accession number0001425450-26-000091

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.